Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 7 recruiting now official registry

Dyspepsia clinical trials

Every US clinical trial registered for Dyspepsia — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.

12 US clinical trials · 7 currently recruiting

The research picture

Dyspepsia has 12 registered US clinical trials, 7 of them open to new participants right now — about 58% of the total.

7
recruiting participants now
58%
of trials open to enrollment
3
in Phase 3–4 (later-stage)
2
top sponsor: Mayo Clinic

Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.

Active & Recent Trials

RECRUITING Phase 3 200 participants

Domperidone in Treating Patients With Gastrointestinal Disorders

M.D. Anderson Cancer Center

NCT01696734

RECRUITING NA 100 participants

Visible Abdominal Distension

Hospital Universitari Vall d'Hebron Research Institute

NCT06369753

RECRUITING NA 100 participants

High Resolution Gastric Mapping and Gastroduodenal Manometry

Mayo Clinic

NCT06941545

RECRUITING Phase 4 80 participants

Famotidine and Antacids for Treatment of Dyspepsia

Stony Brook University

NCT06241183

RECRUITING NA 65 participants

Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

Massachusetts General Hospital

NCT03603730

RECRUITING NA 64 participants

Zypan Functional Dyspepsia

National University of Natural Medicine

NCT06320379

RECRUITING NA 50 participants

Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia

Massachusetts General Hospital

NCT05587127

ACTIVE NOT RECRUITING NA 17 participants

Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility

University of California, Los Angeles

NCT05004012

COMPLETED Phase 3 60 participants

The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.

Novartis

NCT00171470

COMPLETED Phase 1 50 participants

Use of MRI for Assessing Stomach Relaxation in Response to a Meal

Mayo Clinic

NCT00275743

COMPLETED Phase 2 45 participants

Study of Motilitone to Treat Functional Dyspepsia

Dong-A ST Co.

NCT02365701

COMPLETED NA 14 participants

Melatonin in Pediatric FD Population

Children's Mercy Hospital Kansas City

NCT04684199

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 2
Phase 4 1

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Dyspepsia Trial Landscape

ClinicalTrials.gov lists 12 US studies indexed under Dyspepsia, and 7 of those are currently open to recruitment — roughly 58% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Dyspepsia shows 3 late-stage studies (Phase 3 and Phase 4 combined) alongside 2 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Dyspepsia is led by Mayo Clinic with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 12 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Dyspepsia?

PlainTrial tracks 12 US clinical trials for Dyspepsia, of which 7 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Dyspepsia?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →